|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2 negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010 -01 ) 显示文摘 | Charehbili A van de Ven S Smit VT | 2014 | Ann Oncol2014，25，5： | 1 |
| 2 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast can- cer显示文摘 | Van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 3 | Discordances in ER,PRand HER2 receptors after neoadjuvant chemotherapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treatment Re views2011，37，6： | 1 |
| 4 | The role of calpain in oncotic cell death 显示文摘 | Liu X Van VT Schnellmann RG | 2004 | Annu Rev Pharmacol Toxicol2004，44，2： | 1 |
| 5 | Discordances in ER,PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treatment Reviews2011，，37： | 1 |
| 6 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer 显示文摘 | Van DVS Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，： | 1 |
| 7 | Discordances in ER,PR and HER2receptors after neoadjuvant chemotherapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 8 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 9 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer 显示文摘 | Van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 10 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer 显示文摘 | Van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 11 | Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants 显示文摘 | ter Meulen J van den Brink EN Pooh LL Marissen WE Leung CS Cox F Cheung CY Bakker AQ Bogaards JA van Dcventer E Preiser W Doerr HW Chow VT de Kruif J Peiris JS Goudsmit J | 2006 | PLoS Med2006，3，7： | 1 |
| 12 | Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2010 | Cancer Treat Rev2010，20，： | 1 |
| 13 | Addition of zoledronicacid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2 negative stageⅡ/Ⅲ breast cancer: The NEOZOTAC trial( BOOG 2010 -01 ) 显示文摘 | Charehbili A van de Ven S Smit VT | 2014 | Ann Onco12014，2，： | 1 |
| 14 | Fate and transport of antibiotic resistance genes in saturated soil columns显示文摘 | John Pote J Ceccherini MT Van VT | 2003 | Eur J Soil Biol2003，39，： | 1 |
| 15 | Interpre- tation of change and longitudinal validity of the quality of life for respiratory illness questionnaire (QOLRIQ) in inpatient pulmonary rehabilitation 显示文摘 | van Stel HF Maille AR Colland VT | 2003 | Qual Life Res2003，12，2： | 1 |
| 16 | High molecuolar weight DNA recovery from soils prerequisite for biotechnological metagenomic library construction显示文摘 | Bertrand H Poly F Van VT | 2005 | J Microbiol Methods2005，62，1： | 1 |
| 17 | Ery throcytes load of low molecularweight chitosan nanoparticles as a paU*ntial vascular drug deliverysystem 显示文摘 | Fan H Van Vt Xu J el al | 2012 | Colloid Surface Hiointerfaces2012，95，： | 1 |
| 18 | Discordances in ER, PR and Her-2 receptors after neoadjuvant chemothe- rapy in breast cancer显示文摘 | van de Ven S Smit VT Dekker TJ | 2011 | Cancer Treat Rev2011，37，6： | 1 |
| 19 | High molecular weight DNA recovery from soils prerequisite for biotechnological metagenomic library construction显示文摘 | Bertrand H Poly F Van VT | 2005 | Journal of Microbiological Methods2005，62，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员